Sturdivant & Co., Inc.
Research Disclosure

 

Disclosures
Sturdivant & Co.'s Equity Research Disclosure Legend

  1. Sturdivant & Co. managed or co-managed a public offering of this company in the past 12 months.

  2. Sturdivant & Co. received compensation for investment banking services from this security in the past 12 months.

  3. Sturdivant & Co. may seek compensation for investment banking services from the subject company (ies) in the next 3 months.

  4. The research analyst is compensated based on, in part, Sturdivant & Co. profitability, which includes its investment banking revenues.

  5. The research analyst primarily responsible for preparing this research report or a member of the research analyst's household has a financial interest in the securities of the company in the form of options (O), warrants (W), futures (F), and/or a short position.

  6. The research analyst primarily responsible for preparing this research report or a member of the research analyst's household has a financial interest in the securities of the company in the form of a long position in such securities.

Investment opinions are based on each stock's 6-12 month return potential. Our ratings are not based on formal price targets, however our analysts will discuss fair value and/or target price ranges in research reports. Decisions to buy or sell a stock should be based on the investor's investment objectives and risk tolerance and should not rely solely on the rating. Investors should read carefully the entire research report, which provides a more complete discussion of the analyst's views.

Rating System Definitions
Sturdivant & Co.’s stock ratings system reflects the investment decisions our clients face every day, and is meant to assist clients in making these decisions by recommending a specific action to take with each stock we cover. All of the ratings correspond to a specific investment action that we recommend taking on the date the research is published. Thus, “Outperform” (equivalent to “Buy”) ratings are reserved only for stocks that we would be actively buying at the time the research is published. “Marketperform” (equivalent to “Hold”) ratings are reserved for stocks that we believe are in line with the market’s anticipated performance and we recommend holding. “Underperform” (equivalent to “Sell”) ratings are assigned to stocks where the analyst anticipates stock price declines relative to the market. Please note also that the price expectations that determine the rating are in absolute dollar terms, not in terms of relative performance to a sector or an index. Therefore, analysts will not use the “Outperform” rating for stocks that are expected to perform well relative to their sector but only for stocks that are expected to appreciate in actual dollar returns.

This research report is provided for informational purposes only and shall in no event be construed as an offer to sell or a solicitation of an offer to buy any securities. The information described herein is taken from sources which we believe to be reliable, but the accuracy and completeness of such information is not guaranteed by us. The opinions expressed herein may be given only such weight as opinions warrant. This Firm, its officers, directors, employees, or members of their families may have positions in the securities mentioned and may make purchases or sales of such securities from time to time in the open market or otherwise and may sell to or buy from customers such securities on an agency basis. Supporting information related to the recommendation, if any, made in the research report is available upon request.

Please contact Sturdivant & Co., 3000 Atrium Way, Suite 520, Mt. Laurel, New Jersey 08054 (856) 751-1331, for information regarding the disclosures in this document.